Trial Registration: Understanding and Preventing Reporting Bias in Social Work Research

Research on Social Work Practice

Volumn 24, Issue 3, 2014, Pages 372-376

  Harrison, Bronwyn A ^a   Mayo Wilson, Evan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

evidence based practice; literature review; meta analysis; methodological article; methodology; outcome study; randomized experiment; RCT; systematic review

Indexed keywords

EID: 84900321165     PISSN: 10497315     EISSN: 15527581     Source Type: Journal    
DOI: 10.1177/1049731513512374     Document Type: Article

References (33)

1. Beecham, Smith Kline. (1998). A multi-center, double-blind, placebo controlled study of paroxetine and imipramine in adolescents with unipolar major depression-acute phase, Final clinical report, SB Document Number: BRL-029060.
2. Chan A. W.,Hrobjartsson A.,Haahr M. T.,Gotzsche P. C.,Altman D. G.Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles.Journal of the American Medical Association. 2004;291:2457-2465.
3. Counsell C. E.,Clarke M. J.,Slattery J.,Sandercock P. A.The miracle of DICE therapy for acute stroke: Fact or fictional product of subgroup analysis?.British Medical Journal. 1994;309:1677-1681.
4. De Angelis C. D.,Drazen J. M.,Frizelle F. A.,Haug C.,Hoey J.,Horton R.Overbeke A. J. P.Is this clinical trial fully registered?-A statement from the International Committee of Medical Journal Editors.New England Journal of Medicine. 2005;352:2436-2438.
5. Dickersin K.How important is publication bias? A synthesis of available data.AIDS Education and Prevention. 1997;9:15-21.
6. Dwan K.,Altman D. G.,Arnaiz J. A.,Bloom J.,Chan A. W.,Cronin E.Williamson P. R.Systematic review of the empirical evidence of study publication bias and outcome reporting bias.PLoS One. 2008;3:e3081.
7. Dwan K.,Gamble C.,Williamson P. R.,Kirkham J. J.Systematic review of the empirical evidence of study publication bias and outcome reporting bias-An updated review.PLoS One. 2013;8:e66844.
8. Easterbrook P. J.,Gopalan R.,Berlin J.,Matthews D. R.Publication bias in clinical research.The Lancet. 1991;337:867-872.
9. Egger M.,Zellweger-Zahner T.,Schneider M.,Junker C.,Lengeler C.,Antes G.Language bias in randomised controlled trials published in English and German.Lancet. 1997;350:326-329.
10. Food and Drug Administration. (2004). FDA public health advisory: Suicidality in children and adolescents being treated with anti-depressant medications. Retrieved fromhttp://www.fda.gov/cder/drug/antidepressants/SS-RIPHA200410.htm.
11. GoldacreB.HeneghanC.GodleeF.ChalmersI. (2013). Missing trial data-briefing notes. Retrieved fromhttp://www.alltrials.net/wp-content/uploads/2013/01/Missing-trials-briefing-note.pdf.
12. Grant S. P.,Mayo-Wilson E.,Hopewell S.,Macdonald G.,Moher D.,Montgomery P.Developing a reporting guideline for social and psychological intervention trials.Research on Social Work Practice. 2013;23:595-602.
13. Grant S. P.,Mayo-Wilson E.,Melendez-Torres G.,Montgomery P.Reporting quality of social and psychological intervention trials: A systematic review of reporting guidelines and trial publications.PLoS One. 2013;8:e65442.
14. Hutton J.,Williamson P. R.Bias in meta-analysis due to outcome variable selection within studies.Journal of the Royal Statistical Society. 2000;49:359-370.
15. Ioannidis J. P.Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials.Journal of the American Medical Association. 1998;279:281-286.
16. Jureidini J. N.,McHenry L. B.,Mansfield P. R.Clinical trials and drug promotion: Selective reporting of study 329.The International Journal of Risk and Safety in Medicine. 2008;20:73-81.
17. Keller M. B.,Ryan N. D.,Strober M.,Klein R. G.,Kutcher S. P.,Birmaher B.McCafferty J. P.Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial.Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:762-772.
18. Kesselheim A. S.,Avorn J.The role of litigation in defining drug risks.JAMA. 2007;297:308-311.
19. Mathieu S.,Boutron I.,Moher D.,Altman D. G.,Ravaud P.Comparison of registered and published primary outcomes in randomized controlled trials.Journal of the American Medical Association. 2009;302:977-984.
20. McCord J.A thirty-year follow-up of treatment effects.The American psychologist. 1978;33:284-289.
21. Montgomery P.,Grant S. P.,Hopewell S.,Macdonald G.,Moher D.,Michie S.,Mayo-Wilson E.Protocol for CONSORT-SPI: An extension for social and psychological interventions.Implementation Science. 2013;8:99.
22. Montgomery P.,Mayo-Wilson E.Social workers' desk reference. Roberts A. R., ed. Oxford, England: Oxford University Press; 2009:1142-1148.
23. National Institute for Health and Clinical Excellence. (2005). Depression in children and young people: Identification and management in primary, community and secondary care. NICE clinical guideline 28. National Institute for Health and Clinical Excellence: Guidance. Retrieved fromhttp://guidance.nice.org.uk/CG28.
24. Petrosino A.,Turpin-Petrosino C.,Buehler J."Scared straight" and other juvenile awareness programs for preventing juvenile delinquency.The Cochrane Library. 2002;:.
25. Powers E.,Witmer H.,Allport G. W.An experiment in the prevention of delinquency; the Cambridge-Somerville Youth Study. New York, NY: Columbia University Press; 1951:.
26. Rosenthal R.The file drawer problem and tolerance for null results.Psychological bulletin. 1979;86:638.
27. Schulz K. F.Randomised trials, human nature, and reporting guidelines.Lancet. 1996;348:596-598.
28. Schulz K. F.,Altman D. G.,Moher D.CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials.Annals of Internal Medicine. 2010;152:726-732.
29. Simes R. J.Publication bias: The case for an international registry of clinical trials.Journal of Clinical Oncology. 1986;4:1529-1541.
30. Tramer M. R.,Reynolds D. J.,Moore R. A.,McQuay H. J.Impact of covert duplicate publication on meta-analysis: A case study.British Medical Journal. 1997;315:635-640.
31. U.S. Congress. (1997). Food and Drug Administration Modernization Act. Public Law, 105-115.
32. Whittington C. J.,Kendall T.,Fonagy P.,Cottrell D.,Cotgrove A.,Boddington E.Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data.Lancet. 2004;363:1341-1345.
33. Zarin D. A.,Keselman A.Registering a clinical trial in ClinicalTrials.gov.Chest. 2007;131:909-912.